Skip to main content
. 2021 Jun 28;13(7):2220. doi: 10.3390/nu13072220

Table 2.

Measurement of skin hydration using Corneometer® CM825 and transepidermal water loss (TEWL) using Tewameter® TM300.

Evaluation Parameter Group Measurement Sites Week 0 Week 4 Week 8 Week 12
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Corneometer HA Face 49.5 ± 8.53 51.5 ± 6.55 52.8 ± 7.18 ** 54.9 ± 7.06 ***
(AU) 1 Placebo Face 49.1 ± 8.13 49.4 ± 8.79 48.9 ± 9.36 48.8 ± 8.99
HA Arm 33.9 ± 8.41 36.8 ± 6.90 36.1 ± 6.38 38.6 ± 7.99 **
Placebo Arm 35.4 ± 4.91 36.4 ± 5.78 35.1 ± 4.99 35.6 ± 4.38
HA Waist 29.7 ± 7.85 31.9 ± 7.60 30.4 ± 7.20 32.5 ± 7.14 *
Placebo Waist 29.7 ± 5.26 31.0 ± 6.57 29.9 ± 6.38 30.2 ± 5.87
Tewameter HA Face 12.8 ± 2.39 12.1 ± 1.85 12.0 ± 2.65 10.8 ± 2.49 ***††
(g/h/m2) 2 Placebo Face 12.6 ± 3.23 12.9 ± 2.67 13.0 ± 3.45 13.3 ± 3.09
HA Arm 5.79 ± 1.86 5.45 ± 1.89 5.39 ± 2.10 5.40 ± 2.07
Placebo Arm 5.89 ± 2.43 5.94 ±3.06 5.31 ± 2.10 5.57 ± 1.90
HA Waist 3.47 ± 2.18 4.27 ± 1.53 3.60 ± 1.88 4.30 ± 1.88
Placebo Waist 3.74 ± 2.03 3.41 ± 1.32 3.72 ± 2.68 3.83 ± 1.91

1 AU, arbitrary units. 2 g/h/m2: water lost per hour per square meter of skin. * p-values (Dunnett’s test), compared with week 0; * indicates p < 0.05, ** indicates p < 0.01, and *** indicates p < 0.001;  p-values (t-test), comparisons between values in the HA and placebo groups; indicates p < 0.05, and †† indicates p < 0.01. HA, hyaluronan; SD, standard deviation.